Publications:

LKB1/KRAS mutant lung cancers constitute a genetic subset of NSCLC with increased sensitivity to MAPK and mTOR signalling inhibition.

British Journal Of Cancer

Mahoney, C L CL; Choudhury, B B; Davies, H H; Edkins, S S; Greenman, C C; Haaften, G van Gv; Mironenko, T T; Santarius, T T; Stevens, C C; Stratton, M R MR; Futreal, P A PA

Publication Date: 2009-01-27

Variant appearance in text: EGFR: 816C>A

PubMed Link: 19165201

Variant Present in the following documents:

• Main text

View BVdb publication page